trimetazidine has been researched along with Heart Failure in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.90) | 18.2507 |
2000's | 28 (40.58) | 29.6817 |
2010's | 29 (42.03) | 24.3611 |
2020's | 10 (14.49) | 2.80 |
Authors | Studies |
---|---|
Arduini, A; Ceccarelli, SM; Chomienne, O; Gubler, M | 1 |
Aronov, DM; Bubnova, MG | 1 |
Chen, K; Chen, N; Guo, D; Jiao, H; Li, Y; Liu, W; Song, L; Sun, Y; Wei, X; Xue, Y; Yang, K; Yu, M; Yu, T | 1 |
Bahrudin, U; Harjoko, RP; Herminingsih, S; Maharani, N; Sobirin, MA; Tsutsui, H; Uddin, I | 1 |
Min, Z; Qiuhong, S; Ran, Z; Xuelu, L; Yong, M | 1 |
Lu, Y; Ni, H; Shi, H; Sun, Y; Wang, F | 1 |
Chang, J; Choi, HY; Hong, SP; Jin, ES; Kong, MG; Kwon, SS; Park, GM; Park, RW; Park, S | 1 |
Allaart, CP; Bakermans, AJ; Bronzwaer, PNA; de Man, FS; Geurkink, KTJ; Handoko, ML; Kok, WEM; Nederveen, AJ; Oosterveer, FTP; van de Bovenkamp, AA; van Rossum, AC | 1 |
Thadani, U | 1 |
Bohdan, M; Gruchała, M; Moryś, J; Niedoszytko, P; Stopczyńska, I; Wiśniewski, P | 1 |
Fu, B; Ma, S; Zhang, X | 1 |
Breedt, E; Essop, MF; Lacerda, L | 1 |
Kavtaradze, N; Saganelidze, K | 1 |
Lu, X; Ma, X; Wang, J; Wen, J; Yang, Y; Zhang, L; Zhao, Y | 1 |
Coats, CJ; Elliott, PM; Frenneaux, MP; Hyland, R; McKenna, WJ; Moss, L; Omar, R; Pantazis, AA; Pavlou, M; Protonotarios, A; Rantell, K; Tome, M; Watkinson, OT | 1 |
Guo, T; Wang, J | 1 |
Altamirano, R; Castro, PF; Chiong, M; Concepción, R; Enriquez, A; García, L; Jalil, JE; Lavandero, S; Mellado, R; Quintana, JC; Rossel, V; Sepúlveda, L; Sepúlveda, P; Verdejo, HE; Winter, JL | 1 |
Andrikopoulos, G; Manolis, A; Tsioufis, K | 1 |
Chen, J; Zhou, X | 1 |
Banach, M; Chrusciel, P; Rysz, J | 1 |
Fragasso, G; Gowdak, LH; Hamid, MA; Jourdain, P; Lopaschuk, GD; Lopatin, YM; Ponikowski, P; Rosano, GM; Seferovic, PM; Vinereanu, D | 1 |
Sun, A; Wang, P; Xu, L | 1 |
Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
Osmolovskaya, YF; Tereshchenko, SN; Zhirov, IV | 1 |
Arioli, F; Bassanelli, G; Fragasso, G; Margonato, A; Salerno, A; Spoladore, R | 1 |
Akdag, S; Gumrukcuoglu, HA; Gunes, Y; Guntekin, U; Tuncer, M | 1 |
Di Napoli, P | 1 |
Tang, WH | 1 |
Barsotti, A; Di Napoli, P | 1 |
Gunes, Y; Guntekin, U; Sahin, M; Tuncer, M | 2 |
Di Napoli, P; Taccardi, AA | 1 |
Bunc, M; Vrtovec, B; Zemljic, G | 1 |
Arioli, F; Cera, M; Facchini, A; Fragasso, G; Gardini, C; Godino, C; Margonato, A; Marinosci, G; Montanaro, C; Salerno, A; Spoladore, R | 1 |
Magnitskaia, OV; Sedova, EM | 1 |
Mellana, WM; Mohan, D; Palaniswamy, C; Selvaraj, DR | 1 |
Chirkov, YY; Horowitz, JD; Kennedy, JA; Sverdlov, AL | 1 |
Qizhu, T; Wenmeng, W | 1 |
Gao, D; Hao, G; Meng, Z; Ning, N; Niu, X | 1 |
Ashrafian, H; Neubauer, S | 1 |
Arioli, F; Bassanelli, G; Calori, G; Cuko, A; Fragasso, G; Lattuada, G; Luzi, L; Margonato, A; Perseghin, G; Ragogna, F; Salerno, A; Scollo, A; Spoladore, R | 1 |
Kulikov, KG; Shal'nova, SA; Shkol'nik, EL; Vasiuk, IuA | 1 |
Ivanova, EP; Morozova, TE; Rykova, SM | 1 |
Ge, J; Jiang, H; Lu, Y; Sun, A; Zhang, L; Zou, Y | 1 |
Liu, F; Liu, J; Liu, W; Wang, Y; Yin, L; Yu, B; Zhang, L | 1 |
Alberti, L; Baek, SH; Belardinelli, R; Calori, G; Di Napoli, P; Fragasso, G; Kang, SM; Marazzi, G; Margonato, A; Rosano, G; Sahakyan, L; Sanosyan, A; Sisakian, H; Vitale, C | 1 |
Blatter, LA; Dedkova, EN; Seidlmayer, LK | 1 |
Maisch, B; Rupp, H; Zarain-Herzberg, A | 1 |
Bescond-Jacquet, A; Grynberg, A; Helies-Toussaint, C; Lucien, A; Morin, D; Tabbi-Anneni, I | 1 |
Ma, QL; Xie, Y; Zhang, SD | 1 |
Andreadou, I; Cicchitelli, G; Ferrari, R; Guardigli, G; Merli, E | 1 |
Kutuzova, AE; Nedoshivin, AO; Nesterova, IV; Sitnikova, MIu; Sveshnikov, IuG | 1 |
Malmberg, K; Rydén, L; Thrainsdottir, IS; von Bibra, H | 1 |
Efimova, I; Filippov, EA; Garganeeva, AA; Kaliuzhin, VV; Pushnikova, EIu; Sankevich, qV; Stepacheva, TA; Tepliakov, AT; Zavadovskiĭ, KV | 1 |
Essop, MF; Opie, LH | 1 |
Fedorova, TA; Il'ina, IuV; Rybakova, MK; Sotnikova, TI | 1 |
McMurray, JJ; O'Meara, E | 1 |
Calori, G; De Cobelli, F; Del Maschio, A; Esposito, A; Fragasso, G; Lattuada, G; Margonato, A; Palloshi, A; Perseghin, G; Scifo, P | 1 |
Jackson, G | 1 |
Lopaschuk, GD | 1 |
Iushchuk, EN; Khadzegova, AB; Shkol'nik, EL; Vakhromeeva, MN; Vasiuk, IuA; Vit'ko, NK | 1 |
Belardinelli, R; Purcaro, A; Solenghi, M; Volpe, L | 1 |
Iushchuk, EN; Khadzegova, AB; Sadulaeva, IA; Shkol'nik, EL; Vakhromeeva, MN; Vasiuk, IuA; Vit'ko, NK | 1 |
Barkhudaryan, A; Sisakian, H; Torgomyan, A | 1 |
Barsotti, A; Di Giovanni, P; Di Napoli, P; Gaeta, MA; Taccardi, AA | 1 |
Ashrafian, H; Frenneaux, MP; Williams, L | 1 |
Demidova, IV; Drozdov, VN; Levchuk, NN; Tereshchenko, SN | 1 |
Cokkinos, DV | 1 |
Guarnieri, C; Muscari, C | 1 |
20 review(s) available for trimetazidine and Heart Failure
Article | Year |
---|---|
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I | 2018 |
Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis.
Topics: Cardiovascular Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; Heart Failure; Humans; Myocardial Ischemia; Randomized Controlled Trials as Topic; Trimetazidine | 2018 |
Metabolic remodeling in chronic heart failure.
Topics: Adenosine Triphosphate; Carbohydrate Metabolism; Carnitine; Energy Metabolism; Fatty Acids; Fetal Heart; Glucose; Heart Failure; Humans; Neurotransmitter Agents; Thiamine; Trimetazidine; Ventricular Remodeling | 2013 |
Trimetazidine and cardioprotection: facts and perspectives.
Topics: Angina, Stable; Cardiotonic Agents; Chronic Disease; Heart Failure; Humans; Patient Selection; Practice Guidelines as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2015 |
Is treatment with trimetazidine beneficial in patients with chronic heart failure?
Topics: C-Reactive Protein; Chronic Disease; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; PubMed; Randomized Controlled Trials as Topic; Stroke Volume; Trimetazidine; Vasodilator Agents | 2014 |
Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Heart Failure; Humans; Peripheral Arterial Disease; Trimetazidine | 2014 |
Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
Topics: Energy Metabolism; Heart Failure; Humans; Myocardium; Prognosis; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2016 |
Energy Remodeling, Mitochondrial Disorder and Heart Failure.
Topics: Aminoimidazole Carboxamide; Animals; Energy Metabolism; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondrial Diseases; Ribonucleotides; Thiazolidinediones; Trimetazidine | 2016 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
[Trimetazidine in the Treatment of Chronic HeartFailure].
Topics: Chronic Disease; Heart Failure; Humans; Trimetazidine; Vasodilator Agents | 2016 |
Metabolic therapy of heart failure.
Topics: Animals; Cardiovascular Agents; Carnitine O-Palmitoyltransferase; Fatty Acids, Nonesterified; Heart Failure; Humans; Myocardium; Perhexiline; Trimetazidine | 2008 |
The metabolic approach in patients with heart failure: effects on left ventricle remodeling.
Topics: Glucagon-Like Peptide 1; Heart Failure; Humans; Risk Assessment; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2009 |
Prognostic relevance of metabolic approach in patients with heart failure.
Topics: Heart Failure; Humans; Prognosis; Risk Assessment; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Trimetazidine: the future of cardiac function?
Topics: Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents | 2009 |
Metabolic modulation: a new therapeutic target in treatment of heart failure.
Topics: Acetanilides; Carnitine O-Palmitoyltransferase; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Mitochondria, Heart; Myocytes, Cardiac; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2011 |
Modulation of myocardial metabolism: an emerging therapeutic principle.
Topics: Acetanilides; Amiodarone; Cardiovascular Agents; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Reperfusion; Myocardium; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2010 |
Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
Topics: Acetyl-CoA C-Acyltransferase; Adult; Chronic Disease; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Humans; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2011 |
Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
Topics: Disease Progression; Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents; Ventricular Remodeling | 2012 |
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.
Topics: Acetanilides; Angina Pectoris; Animals; Calcium; Cardiovascular Agents; Clinical Trials as Topic; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Gene Expression; Glucose; Heart Failure; Humans; Hypoglycemic Agents; Methylhydrazines; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Trimetazidine; Up-Regulation; Vasodilator Agents | 2002 |
Metabolic modulation and optimization of energy consumption in heart failure.
Topics: Acetanilides; Cardiac Pacing, Artificial; Cardiotonic Agents; Carnitine; Energy Metabolism; Heart Failure; Humans; Piperazines; Ranolazine; Trimetazidine | 2003 |
21 trial(s) available for trimetazidine and Heart Failure
Article | Year |
---|---|
Trimetazidine improves left ventricular global longitudinal strain value in patients with heart failure with reduced ejection fraction due to ischemic heart disease.
Topics: Aged; Heart Failure; Humans; Middle Aged; Myocardial Ischemia; Stroke Volume; Trimetazidine; Ventricular Dysfunction, Left | 2022 |
Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial.
Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Female; Heart Failure; Humans; Male; Phosphocreatine; Stroke Volume; Trimetazidine | 2023 |
Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study.
Topics: Aged; Chronic Disease; Cross-Over Studies; Heart Failure; Humans; Middle Aged; Prospective Studies; Quality of Life; Stroke Volume; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2022 |
Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.
Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Hypertrophic; Exercise Tolerance; Fatty Acids; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Open Bite; Oxygen Consumption; Quality of Life; Trimetazidine; United Kingdom; Vasodilator Agents | 2019 |
Effects of trimetazidine in nonischemic heart failure: a randomized study.
Topics: Adult; Aged; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Radionuclide Imaging; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2014 |
The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
Topics: Chemotherapy, Adjuvant; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2009 |
Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study.
Topics: Aged; Diabetes Complications; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Ventricular Function, Right | 2009 |
Trimetazidine shortens QTc interval in patients with ischemic heart failure.
Topics: Aged; Angiography; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2010 |
Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
Topics: Aged; Aged, 80 and over; Antisocial Personality Disorder; Arrhythmias, Cardiac; Chronic Disease; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Trimetazidine; Vasodilator Agents | 2010 |
[A clinical experience of taurine and trimetazidine use in premenopausal women with chronic heart failure].
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Premenopause; Severity of Illness Index; Taurine; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2010 |
Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
Topics: Aged; Calorimetry; Chronic Disease; Echocardiography; Energy Metabolism; Fatty Acids; Female; Heart Failure; Humans; Male; Oxidation-Reduction; Stroke Volume; Trimetazidine; Vasodilator Agents | 2011 |
[The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women].
Topics: Aged; Angina Pectoris; Cardiotonic Agents; Drug Monitoring; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Nitro Compounds; Russia; Severity of Illness Index; Sex Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2011 |
[Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
Topics: Adult; Aged; Female; Heart Failure; Humans; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2002 |
[Effect of treatment with trimethazidine on characteristics of arrhythmia and indicators of heart rhythm in patients with chronic cardiac failure].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrocardiography, Ambulatory; Heart Failure; Humans; Male; Middle Aged; Trimetazidine | 2003 |
Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure.
Topics: Aged; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Oxygen Consumption; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2004 |
[Anti-ischemic effects of trimetazidine in patients with post-infarction heart failure].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Trimetazidine; Vasodilator Agents | 2004 |
[Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Topics: Aged; Aged, 80 and over; Bisoprolol; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Sympathomimetics; Trimetazidine; Vasodilator Agents | 2004 |
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Double-Blind Method; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Magnetic Resonance Angiography; Male; Phosphocreatine; Prospective Studies; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
Topics: Antioxidants; Cardiomyopathy, Dilated; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Male; Middle Aged; Trimetazidine; Vasodilation; Vasodilator Agents | 2007 |
[Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Diuretics; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Methylhydrazines; Middle Aged; Positron-Emission Tomography; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Topics: Aged; C-Reactive Protein; Cardiomyopathy, Dilated; Echocardiography; Exercise Test; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Stroke Volume; Survival Rate; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Walking | 2007 |
28 other study(ies) available for trimetazidine and Heart Failure
Article | Year |
---|---|
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Ethylene Oxide; Heart Failure; Humans; Insulin Resistance; Isoenzymes; Lipid Metabolism; Myocardial Ischemia; Organ Specificity; Protein Conformation; Sequence Homology, Amino Acid; Stereoisomerism | 2011 |
Efficacy of trimetazidine - an inhibitor of free fatty acids oxidation in the treatment of patients with stable angina pectoris and heart failure.
Topics: Angina, Stable; Fatty Acids, Nonesterified; Heart Failure; Humans; Stroke Volume; Trimetazidine | 2021 |
Protective Effect of Trimetazidine on Potassium Ion Homeostasis in Myocardial Tissue in Mice with Heart Failure.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Heart Failure; Homeostasis; Mice; Potassium; Sodium; Trimetazidine | 2022 |
Effectiveness of Trimetazidine in Patients with Chronic Heart Failure Stratified by the Expression of Soluble Suppression of Tumorigenicity-2 (sST2): A Prospective Cohort Study.
Topics: Biomarkers; Chronic Disease; Heart Failure; Humans; Prospective Studies; Quality of Life; Trimetazidine | 2022 |
Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine.
Topics: Aged; Cardiovascular Diseases; China; Coronary Disease; Glucose; Heart Failure; Humans; Metoprolol; Middle Aged; Trimetazidine | 2022 |
Impact of Trimetazidine on the Incident Heart Failure After Coronary Artery Revascularization.
Topics: Angina Pectoris; Coronary Vessels; Heart Failure; Humans; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2023 |
Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data?
Topics: Angina Pectoris; Heart Failure; Humans; Myocardial Ischemia; Trimetazidine | 2020 |
Effects of trimetazidine in combination with bisoprolol in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Meta-Analysis as Topic; Observational Studies as Topic; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2021 |
Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure.
Topics: Acute Disease; Animals; Cardiotonic Agents; Diabetes Mellitus, Experimental; Female; Heart; Heart Failure; Heart Rate; In Vitro Techniques; Male; Mice; Mice, Obese; Models, Biological; Sex Factors; Trimetazidine; Ventricular Function | 2017 |
The metabolic treatment of coronary artery disease and heart failure.
Topics: Carnitine O-Palmitoyltransferase; Coronary Artery Disease; Epoxy Compounds; Heart Failure; Humans; Perhexiline; Trimetazidine; Vasodilator Agents | 2009 |
The effects of trimetazidine on heart rate variability in patients with heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Treatment Outcome; Trimetazidine; Ultrasonography; Vasodilator Agents | 2009 |
Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.
Topics: Animals; Diabetes Mellitus; Diabetic Cardiomyopathies; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Models, Theoretical; Myocardial Ischemia; Myocardium; Research Design; Risk Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2011 |
Metabolic modulation in heart failure: high time for a definitive clinical trial.
Topics: Acetyl-CoA C-Acyltransferase; Chronic Disease; Enzyme Inhibitors; Heart Failure; Humans; Meta-Analysis as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2011 |
[Clinico-economical aspects of application of trimetazidine MB in patients with chronic heart failure and cardiac rhythm disturbances].
Topics: Aged; Arrhythmias, Cardiac; Chronic Disease; Costs and Cost Analysis; Disease Management; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Remission Induction; Severity of Illness Index; Trimetazidine; Vasodilator Agents | 2011 |
Trimetazidine improves right ventricular function by increasing miR-21 expression.
Topics: Animals; Cells, Cultured; Heart Failure; Heart Ventricles; MicroRNAs; Rats; Rats, Sprague-Dawley; Trimetazidine; Up-Regulation; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 2012 |
Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study.
Topics: Aged; Aged, 80 and over; Cohort Studies; Fatty Acids; Female; Follow-Up Studies; Heart Failure; Humans; Internationality; Male; Middle Aged; Morbidity; Oxidation-Reduction; Retrospective Studies; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2013 |
Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure.
Topics: Acetyl-CoA C-Acyltransferase; Animals; Calcium; Electron Transport; Heart Failure; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nitric Oxide Synthase; Rabbits; Reactive Oxygen Species; Trimetazidine | 2013 |
Prevention of heart failure in rats by trimetazidine treatment: a consequence of accelerated phospholipid turnover?
Topics: Animals; Disease Models, Animal; Heart Failure; Male; Natriuretic Peptide, Brain; Organ Size; Phospholipids; Rats; Rats, Wistar; Receptors, Adrenergic; Trimetazidine; Vasodilator Agents | 2003 |
Metabolic therapy for heart failure.
Topics: Fatty Acids, Nonesterified; Heart Failure; Humans; Mitochondria; Myocardial Contraction; Oxygen; Quality of Life; Trimetazidine; Vasodilator Agents | 2004 |
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
Topics: Blood Glucose; Fatty Acids, Nonesterified; Heart Failure; Humans; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents | 2005 |
Metabolic approach to heart failure - evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis.
Topics: Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
Topics: Animals; Dichloroacetic Acid; Fatty Acids; Glucose; Heart Failure; Humans; Insulin; Myocardium; Trimetazidine | 2006 |
[Possibilities of myocardial cytoprotection in complex treatment of patients with chronic heart failure].
Topics: Aged; Cytoprotection; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardium; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2006 |
The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Exercise Test; Exercise Tolerance; Female; Health Status Indicators; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Motor Activity; Myocardial Ischemia; Prospective Studies; Stroke Volume; Systole; Trimetazidine; Vasodilator Agents | 2007 |
The pathophysiology of heart failure: a tale of two old paradigms revisited.
Topics: Cardiovascular Agents; Cardiovascular Physiological Phenomena; Clinical Trials as Topic; Heart Failure; Humans; Metabolic Networks and Pathways; Perhexiline; Trimetazidine; Vasodilator Agents | 2008 |
[Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure].
Topics: Acid Phosphatase; Adult; Aged; Biomarkers; Blood Coagulation Factors; Cholesterol, HDL; Chronic Disease; Creatinine; Female; Follow-Up Studies; Heart Failure; Hemostasis; Humans; Male; Middle Aged; Plasma; Treatment Outcome; Triglycerides; Trimetazidine; Vasodilator Agents | 1998 |
Can metabolic manipulation reverse myocardial dysfunction?
Topics: Heart Failure; Humans; Myocardial Ischemia; Trimetazidine; Vasodilator Agents | 2001 |
Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle.
Topics: Animals; Heart Failure; Male; Mitochondria, Heart; Monocrotaline; Plants, Toxic; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Senecio; Superoxides; Trimetazidine | 1990 |